サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1303568

プロゲステロンの世界市場規模調査＆予測：タイプ別、送達様式別、用途別、地域別分析、2023-2030年

Global Progesterone Market Size study & Forecast, by Type, By Mode of Delivery, By Application and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
プロゲステロンの世界市場規模調査＆予測：タイプ別、送達様式別、用途別、地域別分析、2023-2030年
出版日: 2023年07月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

プロゲステロンの世界市場は、2022年に約11億5,720万米ドルと評価され、予測期間2023-2030年には13.3％以上の健全な成長率で成長すると予測されています。

プロゲステロンは、主に排卵後に卵巣で産生される女性ホルモンです。妊娠のために子宮を準備し、健康な妊娠を維持する上で重要な役割を果たしています。プロゲステロンはまた、月経周期の調節を助け、乳房組織の発達にも関与しています。また、生理不順、不妊症、更年期障害など、さまざまな症状の治療薬としても使用されます。更年期女性のホルモン補充療法の一環として処方されることも多いです。プロゲステロン市場は、子宮内膜がんの罹患率の増加、女性不妊症や乳がんの症例の増加などの要因により拡大しています。

妊娠中、プロゲステロンのレベルは著しく上昇し、子宮の早期収縮を防ぐのに役立ちます。閉経後は、エストロゲンとともにプロゲステロンの分泌が減少し、ほてり、膣の乾燥、骨量減少などの症状を引き起こします。ここ数十年の間に、その有病率は徐々に増加しています。米国がん協会によると、2023年には新たに約66,200例の子宮体がんが診断されます。さらに、米国では約13,030人の女性が子宮体部のがんで死亡します。さらに、同年に浸潤性子宮頸がんが新たに13,960例診断され、4,310人の女性が子宮頸がんで死亡します。スペースを牽引するもうひとつの重要な要素は、女性の不妊症と乳がんの症例が増加していることです。世界保健機関（WHO）によると、2020年には世界で230万人の女性が乳がんと診断され、685,000人が死亡します。また、米国臨床腫瘍学会によると、2023年には米国で297,790人の女性が浸潤性乳がんと診断され、55,720人の女性が非浸潤性乳がんと診断されると推定されています。また、医療業界における製剤の進歩や技術の進歩は、予測期間にわたって市場に有利な成長見通しを生み出すと思われます。しかし、ホルモン療法の利用可能性に関する認識不足が、2023～2030年の予測期間を通じて市場の成長を阻害します。

プロゲステロンの世界市場調査において考慮された主要地域は以下の通りです：アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカ。北米は、同地域における乳がんの増加により、2022年の市場を独占しました。Breastcancer.orgによると、2022年には、米国で新たに287,850例の浸潤性乳がんが女性に診断され、51,400例の非浸潤性乳がんが新たに診断されると予測されています。アジア太平洋地域は、市場参入企業の増加、政府機関や非営利団体の積極的な参入などの要因により、予測期間中に大きく成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • プロゲステロン市場：地域別、2020-2030年
    • プロゲステロン市場、タイプ別、2020-2030年
    • プロゲステロン市場：送達様式別、2020-2030年
    • プロゲステロン市場：用途別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査想定

第2章 プロゲステロンの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 プロゲステロンの世界市場力学

  • プロゲステロン市場のインパクト分析（2020-2030年）
    • 市場促進要因
      • 子宮内膜がんの増加
      • 女性不妊症と乳がん患者の増加
    • 市場の課題
      • ホルモン療法に対する認識不足
    • 市場機会
      • 製剤の進歩
      • 医療産業における技術の進歩

第4章 プロゲステロンの世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 プロゲステロンの世界市場：タイプ別

  • 市場スナップショット
  • プロゲステロンの世界市場：タイプ別、実績-潜在能力分析
  • プロゲステロンの世界市場：タイプ別、推定・予測2020-2030
  • プロゲステロン市場、サブセグメント分析
    • 天然プロゲステロン
    • 合成プロゲステロン

第6章 プロゲステロンの世界市場：送達様式別

  • 市場スナップショット
  • プロゲステロンの世界市場、送達様式別、実績-潜在能力分析
  • プロゲステロンの世界市場、送達様式別、推定・予測2020-2030
  • プロゲステロン市場、サブセグメント分析
    • 注射剤
    • 懸濁液
    • 経口剤

第7章 プロゲステロンの世界市場：用途別

  • 市場スナップショット
  • プロゲステロンの世界市場：用途別、実績-潜在能力分析
  • プロゲステロンの世界市場、用途別、推定・予測2020-2030
  • プロゲステロン市場、サブセグメント分析
    • 月経周期の調節
    • 機能不全性子宮出血
    • 子宮内膜がん
    • 避妊
    • 過形成前駆病変

第8章 プロゲステロンの世界市場、地域分析

  • 主要国
  • 主な新興国
  • プロゲステロン市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプの推定・予測、2020-2030年
      • 投与形態の推定・予測、2020-2030年
      • 用途の推定・予測、2020-2030年
    • カナダ
  • 欧州プロゲステロン市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋プロゲステロン市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのプロゲステロン市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Estrellas Life Sciences Private Ltd
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Bionpharma Inc.
    • Sofgen Pharmaceuticals
    • Teva Pharmaceuticals Industries Ltd
    • Virtus Pharmaceuticals Llc,
    • Blubell Pharma Group Company
    • Aquatic Remedies Pvt. Ltd.
    • Intas Pharmaceuticals Ltd.
    • Shanghai Yijing Industrial Co ltd
    • Wuhan Honor Bio-Pharm Co., Ltd

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提
図表

LIST OF TABLES

  • TABLE 1. Global Progesterone Market, report scope
  • TABLE 2. Global Progesterone Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3. Global Progesterone Market estimates & forecasts by Type 2020-2030 (USD Million)
  • TABLE 4. Global Progesterone Market estimates & forecasts by Mode of Delivery 2020-2030 (USD Million)
  • TABLE 5. Global Progesterone Market estimates & forecasts by Application 2020-2030 (USD Million)
  • TABLE 6. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16. U.S. Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 17. U.S. Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18. U.S. Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 19. Canada Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 20. Canada Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21. Canada Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 22. UK Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 23. UK Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24. UK Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 25. Germany Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 26. Germany Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27. Germany Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 28. France Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 29. France Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30. France Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 31. Italy Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 32. Italy Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33. Italy Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 34. Spain Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 35. Spain Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36. Spain Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 37. RoE Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 38. RoE Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39. RoE Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 40. China Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 41. China Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42. China Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 43. India Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 44. India Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45. India Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 46. Japan Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 47. Japan Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48. Japan Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 49. South Korea Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 50. South Korea Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51. South Korea Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 52. Australia Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 53. Australia Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54. Australia Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 55. RoAPAC Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 56. RoAPAC Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57. RoAPAC Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 58. Brazil Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 59. Brazil Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60. Brazil Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 61. Mexico Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 62. Mexico Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63. Mexico Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 64. RoLA Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 65. RoLA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66. RoLA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 67. Saudi Arabia Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 68. South Africa Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69. RoMEA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Progesterone Market
  • TABLE 71. List of primary sources, used in the study of global Progesterone Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Progesterone Market, research methodology
  • FIG 2. Global Progesterone Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Progesterone Market, key trends 2022
  • FIG 5. Global Progesterone Market, growth prospects 2023-2030
  • FIG 6. Global Progesterone Market, porters 5 force model
  • FIG 7. Global Progesterone Market, pest analysis
  • FIG 8. Global Progesterone Market, value chain analysis
  • FIG 9. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
  • FIG 10. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
  • FIG 11. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
  • FIG 12. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
  • FIG 13. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
  • FIG 14. Global Progesterone Market, regional snapshot 2020 & 2030
  • FIG 15. North America Progesterone Market 2020 & 2030 (USD Million)
  • FIG 16. Europe Progesterone Market 2020 & 2030 (USD Million)
  • FIG 17. Asia Pacific Progesterone Market 2020 & 2030 (USD Million)
  • FIG 18. Latin America Progesterone Market 2020 & 2030 (USD Million)
  • FIG 19. Middle East & Africa Progesterone Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Progesterone Market is valued at approximately USD 1157.2 million in 2022 and is anticipated to grow with a healthy growth rate of more than 13.3% over the forecast period 2023-2030. Progesterone is a female hormone that is primarily produced by the ovaries after ovulation. It plays a crucial role in preparing the uterus for pregnancy and maintaining a healthy pregnancy. Progesterone also helps regulate the menstrual cycle and is involved in the development of breast tissue. It can also be used as a medication to treat various conditions, such as irregular periods, infertility, and menopausal symptoms. It is often prescribed as part of hormone replacement therapy for menopausal women. The Progesterone market is expanding because of factors such increasing incidence of endometrial cancer and growing cases of female infertility and breast cancer.

During pregnancy, progesterone levels rise significantly and help to prevent premature contractions of the uterus. After menopause, progesterone production declines, along with estrogen, which can lead to symptoms such as hot flashes, vaginal dryness, and bone loss. Its prevalence has progressively increased during the last few decades. According to the American Cancer Society, in 2023 about 66,200 new cases of cancer of the body of the uterus will be diagnosed. Furthermore, around 13,030 women will die from cancers of the uterine body in the United States. In addition, about 13,960 new cases of invasive cervical cancer will be diagnosed and 4,310 women will die from cervical cancer during the same year. Another important component driving space is increasing cases of female infertility and breast cancer. According to World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. In addition, as per the American Society of Clinical Oncology in 2023, an estimated 297,790 women in the United States will be diagnosed with invasive breast cancer, and 55,720 women will be diagnosed with non-invasive breast cancer. Also, advancements in formulation and technological advancements in the medical industry would create a lucrative growth prospectus for the market over the forecast period. However, lack of awareness regarding the availability of hormone therapy stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Progesterone Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing number of breast cancer in the region. According to Breastcancer.org, In 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 51,400 new cases of non-invasive breast cancer. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising target populations, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Estrellas Life Sciences Private Ltd
  • Bionpharma Inc.,
  • Sofgen Pharmaceuticals,
  • Teva Pharmaceuticals Industries Ltd
  • Virtus Pharmaceuticals Llc,
  • Blubell Pharma Group Company, Aquatic Remedies Pvt. Ltd.,
  • Intas Pharmaceuticals Ltd.,
  • Shanghai Yijing Industrial Co ltd
  • Wuhan Honor Bio-Pharm Co., Ltd

Recent Developments in the Market:

  • In November 2020, Prestige BioPharma Ltd. and Abic Marketing Ltd., a subsidiary of Teva Pharmaceutical Industries Ltd., signed an exclusive cooperation and supply agreement for the commercialization of Prestige BioPharma's Trastuzumab biosimilar in Israel.

Global Progesterone Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Mode of Delivery, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type

  • Natural Progesterone
  • Synthetic Progesterone

By Mode of Delivery

  • Injectable
  • Suspended Form
  • Oral

By Application

  • Regulation of the Menstrual Cycle
  • Dysfunctional Uterine Bleeding
  • Endometrial Cancer
  • Contraception
  • Hyperplastic Precursor Lesions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Progesterone Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Progesterone Market, by Type, 2020-2030 (USD Million)
    • 1.2.3. Progesterone Market, by Mode of Delivery, 2020-2030 (USD Million)
    • 1.2.4. Progesterone Market, by Application, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Progesterone Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Progesterone Market Dynamics

  • 3.1. Progesterone Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of endometrial cancer
      • 3.1.1.2. Growing cases of female infertility and breast cancer
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of awareness regarding the availability of hormone therapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in Formulation
      • 3.1.3.2. Technological Advancements in the Medical Industry

Chapter 4. Global Progesterone Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Progesterone Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Progesterone Market by Type, Performance - Potential Analysis
  • 5.3. Global Progesterone Market Estimates & Forecasts by Type 2020-2030 (USD Million)
  • 5.4. Progesterone Market, Sub Segment Analysis
    • 5.4.1. Natural Progesterone
    • 5.4.2. Synthetic Progesterone

Chapter 6. Global Progesterone Market, by Mode of Delivery

  • 6.1. Market Snapshot
  • 6.2. Global Progesterone Market by Mode of Delivery, Performance - Potential Analysis
  • 6.3. Global Progesterone Market Estimates & Forecasts by Mode of Delivery 2020-2030 (USD Million)
  • 6.4. Progesterone Market, Sub Segment Analysis
    • 6.4.1. Injectable
    • 6.4.2. Suspended Form
    • 6.4.3. Oral

Chapter 7. Global Progesterone Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Progesterone Market by Application, Performance - Potential Analysis
  • 7.3. Global Progesterone Market Estimates & Forecasts by Application 2020-2030 (USD Million)
  • 7.4. Progesterone Market, Sub Segment Analysis
    • 7.4.1. Regulation of the Menstrual Cycle
    • 7.4.2. Dysfunctional Uterine Bleeding
    • 7.4.3. Endometrial Cancer
    • 7.4.4. Contraception
    • 7.4.5. Hyperplastic Precursor Lesions

Chapter 8. Global Progesterone Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Progesterone Market, Regional Market Snapshot
  • 8.4. North America Progesterone Market
    • 8.4.1. U.S. Progesterone Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Mode of Delivery breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Progesterone Market
  • 8.5. Europe Progesterone Market Snapshot
    • 8.5.1. U.K. Progesterone Market
    • 8.5.2. Germany Progesterone Market
    • 8.5.3. France Progesterone Market
    • 8.5.4. Spain Progesterone Market
    • 8.5.5. Italy Progesterone Market
    • 8.5.6. Rest of Europe Progesterone Market
  • 8.6. Asia-Pacific Progesterone Market Snapshot
    • 8.6.1. China Progesterone Market
    • 8.6.2. India Progesterone Market
    • 8.6.3. Japan Progesterone Market
    • 8.6.4. Australia Progesterone Market
    • 8.6.5. South Korea Progesterone Market
    • 8.6.6. Rest of Asia Pacific Progesterone Market
  • 8.7. Latin America Progesterone Market Snapshot
    • 8.7.1. Brazil Progesterone Market
    • 8.7.2. Mexico Progesterone Market
  • 8.8. Middle East & Africa Progesterone Market
    • 8.8.1. Saudi Arabia Progesterone Market
    • 8.8.2. South Africa Progesterone Market
    • 8.8.3. Rest of Middle East & Africa Progesterone Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Estrellas Life Sciences Private Ltd
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Bionpharma Inc.
    • 9.3.3. Sofgen Pharmaceuticals
    • 9.3.4. Teva Pharmaceuticals Industries Ltd
    • 9.3.5. Virtus Pharmaceuticals Llc,
    • 9.3.6. Blubell Pharma Group Company
    • 9.3.7. Aquatic Remedies Pvt. Ltd.
    • 9.3.8. Intas Pharmaceuticals Ltd.
    • 9.3.9. Shanghai Yijing Industrial Co ltd
    • 9.3.10. Wuhan Honor Bio-Pharm Co., Ltd

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption